Oregon Medicaid enrollees are less likely to make unscheduled trips to the hospital following the implementation of the state's accountable-care model, new research by Oregon State University shows.
Oct 7, 2019
0
0
A third (34 per cent) of eczema management mobile applications provide information that does not agree with international treatment and condition guidelines, a study led by Nanyang Technological University, Singapore (NTU ...
Jun 11, 2019
0
5
When treating patients, doctors sometimes overlook how their decisions impact a world they never see: a patient's home life. In the case of some serious infections in children, oral antimicrobial drugs are just as good at ...
Mar 25, 2019
0
3
Early specialist palliative care treatment does not improve the quality of life for patients diagnosed with the rare cancer mesothelioma when compared to standard care alone, new research led by Curtin University has found.
Mar 21, 2019
0
5
(HealthDay)—The U.S. Food and Drug Administration on Tuesday approved a new generic version of the high blood pressure/heart failure drug valsartan, saying the move might help ease the current medication shortage.
Mar 13, 2019
0
2
(HealthDay)—A policy introducing nutrition standards for competitive beverages can improve the nutritional quality of beverages sold in schools, according to a study published online March 3 in the U.S. Centers for Disease ...
Mar 9, 2016
0
0
A new review by the International Osteoporosis Foundation (IOF) has confirmed the success of the Capture the Fracture; Best Practice Framework as a single set of quality standards which can be used effectively to benchmark ...
Jun 22, 2015
0
6
The government is rewriting sweeping new food safety rules after farmers complained that they could hurt business.
Sep 19, 2014
0
0
A two-step decision tree analysis, incorporating Donabedian's model, is a feasible process to evaluate and distill the many available quality standards, guidelines, recommendations and indicators in order to update national ...
Jul 28, 2014
0
0
U.S. health regulators said Thursday they are barring imported drugs from an overseas factory operated by Ranbaxy Laboratories, India's largest drugmaker, due to quality control violations.
Jan 23, 2014
0
0
